Cargando…

Development of novel 5-FU modified siRNA against BCL-2 with enhanced efficacy and vehicle-free cellular uptake

Detalles Bibliográficos
Autores principales:	Fesler, Andrew, Hwang, Ga-Ram, Ju, Jingfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2022
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425747/ https://www.ncbi.nlm.nih.gov/pubmed/37588189 http://dx.doi.org/10.1016/j.gendis.2022.11.020

Ejemplares similares

Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer
por: Hwang, Ga-Ram, et al.
Publicado: (2023)

Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1
por: Fesler, Andrew, et al.
Publicado: (2017)

Carrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group
por: Petrova, Natalya S., et al.
Publicado: (2012)

In Vitro Cellular Uptake and Transfection of Oligoarginine-Conjugated Glycol Chitosan/siRNA Nanoparticles
por: Jeong, Eun-Ju, et al.
Publicado: (2021)

Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA
por: Yoon, Hong Yeol, et al.
Publicado: (2014)

Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation
por: Kubota, Kohei, et al.
Publicado: (2017)

Guanabenz (Wytensin™) selectively enhances uptake and efficacy of hydrophobically modified siRNAs
por: Osborn, Maire F., et al.
Publicado: (2015)

Visualization of self-delivering hydrophobically modified siRNA cellular internalization
por: Ly, Socheata, et al.
Publicado: (2017)

Disulfide-Based Poly(amido amine)s for siRNA Delivery: Effects of Structure on siRNA Complexation, Cellular Uptake, Gene Silencing and Toxicity
por: Vader, Pieter, et al.
Publicado: (2010)

Inhibition of Mus81 by siRNA enhances sensitivity to 5-FU in breast carcinoma cell lines
por: Qian, Ying, et al.
Publicado: (2014)

Effective carrier-free gene-silencing activity of cholesterol-modified siRNAs
por: Salim, Lidya, et al.
Publicado: (2018)

Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
por: Li, Weiping, et al.
Publicado: (2019)

Single-Stranded Phosphorothioated Regions Enhance Cellular Uptake of Cholesterol-Conjugated siRNA but Not Silencing Efficacy
por: Ly, Socheata, et al.
Publicado: (2020)

PAMAM versus PEI complexation for siRNA delivery: interaction with model lipid membranes and cellular uptake
por: Chang, Patrick K. C., et al.
Publicado: (2022)

Acetylation of PAMAM dendrimers for cellular delivery of siRNA
por: Waite, Carolyn L, et al.
Publicado: (2009)

iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma
por: Liu, Qinhua, et al.
Publicado: (2022)

Cellular Uptake of siRNA-Loaded Nanocarriers to Knockdown PD-L1: Strategies to Improve T-cell Functions
por: Thiramanas, Raweewan, et al.
Publicado: (2020)

Gene expression profiles in BCL11B-siRNA treated malignant T cells
por: Huang, Xin, et al.
Publicado: (2011)

Complete chloroplast genome features and phylogenetic analysis of Abies ernestii var. salouenensis (Bordères and Gaussen) W. C. Cheng and L. K. Fu from southwest China
por: Shao, Yi-Zhen, et al.
Publicado: (2023)

Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells
por: KUNZE, DOREEN, et al.
Publicado: (2012)

Uptake and intracellular traffic of siRNA dendriplexes in glioblastoma cells and macrophages
por: Perez, Ana Paula, et al.
Publicado: (2011)

Synergistic effect of BCL2 and FLT3 co-inhibition in acute myeloid leukemia
por: Brinton, Lindsey T., et al.
Publicado: (2020)

siRNAmod: A database of experimentally validated chemically modified siRNAs
por: Dar, Showkat Ahmad, et al.
Publicado: (2016)

An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma
por: Shen, Min, et al.
Publicado: (2012)

Combination of BCL11A siRNA with vincristine increases the apoptosis of SUDHL6 cells
por: He, Dongmei, et al.
Publicado: (2014)

bcl-2-specific siRNAs restore Gemcitabine sensitivity in human pancreatic cancer cells
por: Okamoto, Kinya, et al.
Publicado: (2007)

Polyethylenimine-Conjugated Hydroxyethyl Cellulose for Doxorubicin/Bcl-2 siRNA Co-Delivery Systems
por: Park, Jiwon, et al.
Publicado: (2023)

Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma
por: Liu, Yuanhui, et al.
Publicado: (2019)

5-FU-miR-15a Inhibits Activation of Pancreatic Stellate Cells by Reducing YAP1 and BCL-2 Levels In Vitro
por: Almanzar, Vanessa M. Diaz, et al.
Publicado: (2023)

Modified-Chitosan/siRNA Nanoparticles Downregulate Cellular CDX2 Expression and Cross the Gastric Mucus Barrier
por: Sadio, Ana, et al.
Publicado: (2014)

Pathways of cellular internalisation of liposomes delivered siRNA and effects on siRNA engagement with target mRNA and silencing in cancer cells
por: Alshehri, Abdullah, et al.
Publicado: (2018)

Development of microRNA-based therapy for pancreatic cancer
por: Fesler, Andrew, et al.
Publicado: (2019)

Inhibition of MDR1 expression with altritol-modified siRNAs
por: Fisher, Michael, et al.
Publicado: (2007)

Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing
por: Vollmann, Elisabeth H., et al.
Publicado: (2017)

A dual function TAR Decoy serves as an anti-HIV siRNA delivery vehicle
por: Unwalla, Hoshang J, et al.
Publicado: (2010)

Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

A supramolecular platform for controlling and optimizing molecular architectures of siRNA targeted delivery vehicles
por: Wen, Yuting, et al.
Publicado: (2020)

D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming
por: Tan, Xi, et al.
Publicado: (2019)

Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma
por: Guo, Shixiang, et al.
Publicado: (2019)

Liver-Targeted Combination Therapy Basing on Glycyrrhizic Acid-Modified DSPE-PEG-PEI Nanoparticles for Co-delivery of Doxorubicin and Bcl-2 siRNA
por: Tian, Guixiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a3up60r6bb28eriiv0ilgoqpa7